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Endovascular treatment of iliofemoral deep vein thrombosis in 
pregnancy using US-guided percutaneous aspiration thrombectomy
Murat Gedikoglu
Levent Oguzkurt
Pregnancy is a risk factor for venous thromboembolism (VTE) and the risk is highest in the postpartum period (1, 2). Anticoagulants are very effective in the prevention of pulmonary embolism (PE) and recurrent thrombosis, but the treatment of deep vein 
thrombosis (DVT) remains a challenge, because lysis of the thrombus formed in the deep 
veins is slow and frequently inadequate as a therapy (3, 4). Complete or significant lysis 
occurs only in 4% of patients treated with heparin alone (3). Persistence of thrombus within 
deep veins leads to venous hypertension, which is ultimately the cause of post-thrombotic 
syndrome (PTS) and late disability in 20% to 50% of patients. PTS is a conglomerate of life-
style-limiting symptoms that commonly includes chronic leg pain and swelling, heaviness, 
and/or fatigue, venous claudication, stasis dermatitis, and in advanced cases skin ulcer-
ations due to valvular incompetence accompanied by persistent venous outflow obstruc-
tion (4–8). Pregnant women are generally younger than other women in the general popu-
lation, and they likely suffer a more severe form of PTS for a much longer time.
Anticoagulants have been the standard therapy of DVT in pregnant women because of 
concerns related to administering contrast agent, exposing the fetus to radiation during 
interventional radiologic procedures, and bleeding complication associated with throm-
bolysis (9). Nonetheless, there are a few publications describing thrombolytic therapy 
of DVT with good success during pregnancy and peri- or postpartum period (10–13). 
In a previous study (14), a pregnant woman with DVT was treated using percutaneous 
mechanical thrombectomy under venographic guidance with contrast agent. Percuta-
neous aspiration thrombectomy (PAT) with or without fluoroscopy guidance in preg-
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PURPOSE 
We aimed to describe ultrasonography (US)-guided percutaneous aspiration thrombectomy in 
pregnant women with iliofemoral deep vein thrombosis. 
METHODS
This study included nine pregnant women with acute and subacute iliofemoral deep vein throm-
bosis, who were severe symptomatic cases with massive swelling and pain of the leg. Patients 
were excluded from the study if they had only femoropopliteal deep vein thrombosis or mild 
symptoms of deep vein thrombosis. US-guided percutaneous aspiration thrombectomy was ap-
plied to achieve thrombus removal and uninterrupted venous flow. The treatment was consid-
ered successful if there was adequate venous patency and symptomatic relief.
RESULTS
Complete or significant thrombus removal and uninterrupted venous flow from the puncture 
site up to the iliac veins were achieved in all patients at first intervention. Complete relief of leg 
pain was achieved immediately in seven patients (77.8%). Two patients (22.2%) had a recurrence 
of thrombosis in the first week postintervention. One of them underwent a second intervention, 
where percutaneous aspiration thrombectomy was performed again with successful removal of 
thrombus and establishment of in line flow. Two patients were lost to follow-up after birth. None 
of the remaining seven patients had rethrombosis throughout the postpartum period. Symp-
tomatic relief was detected clinically in these patients.
CONCLUSION
Endovascular treatment with US-guided percutaneous aspiration thrombectomy can be consid-
ered as a safe and effective way to remove thrombus from the deep veins in pregnant women 
with acute and subacute iliofemoral deep vein thrombosis.  
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nant women with iliofemoral DVT has not 
been reported to date. We aimed to report 
the technical feasibility and initial success 
of ultrasonography (US)-guided PAT as a 
thrombus removal method in pregnant 
women with acute and subacute iliofem-
oral DVT. 
Methods 
Patients 
Following institutional review board 
approval, we conducted a retrospective 
search of pregnant patients with symp-
tomatic acute and/or subacute iliofemoral 
DVT treated with PAT under real-time US 
guidance. This study was limited to nine 
pregnant women who had massive leg 
swelling similar to phlegmasia alba dolens. 
The exclusion criteria were asymptomatic 
or mild cases, femoropopliteal DVT only, 
any previous surgery or intervention con-
cerning the leg veins, thrombus in the in-
ferior vena cava, symptomatic PE, acute on 
top of chronic DVT, acute infection at the 
puncture site, and contraindication to hep-
arin treatment. Mean age of patients was 
29.7±5.03 years (range, 24–36 years).
The diagnosis was confirmed by color 
Doppler US (CDUS). Because ionizing radi-
ation is potentially hazardous to the fetus, 
we did not perform conventional venog-
raphy. Iliac, femoral, popliteal, crural veins, 
as well as great and small saphenous veins 
(GSV and SSV) were examined with CDUS. 
Intravenous unfractionated heparin or sub-
cutaneous low-molecular weight heparin 
was started as soon as a diagnosis of DVT 
was made. Endovascular treatment using 
PAT under US guidance was proposed to all 
patients for the best long-term outcome.
 
Procedure 
All thrombus removal procedures were 
carried out using PAT under US guidance. 
Before initiation of PAT, potential risks and 
benefits were explained in detail, and a writ-
ten consent was obtained from all patients.
The patients were positioned prone or 
semi-prone on the operating table and 
monitored with blood pressure measure-
ment and pulse oximetry throughout the 
procedure. Skin and subcutaneous tissue 
were infiltrated with 1–2 mL of 1% lido-
caine using a 25G needle. After puncture 
of the ipsilateral popliteal vein under US 
guidance (Antares, Siemens) with a 21G or 
18G needle, a 9 F or 10 F vascular sheath 
was placed (Fig. 1a, 1b). GSV and SSV were 
also accessed, when the thrombus extend-
ed to this vein. The procedure was carried 
out with local anesthesia in all patients. 
Propofol (0.5 mg/kg) was administered as 
intermittent intravenous bolus to achieve 
procedural sedation, if required. Heparin 
was administered intravenously as an initial 
bolus of 5000 U followed by 2500 U every 
45 minutes throughout the procedure. PAT 
was performed cautiously using large bore 
(7 F to 9 F) guiding catheters (Fig. 1c) con-
nected to a 20 mL syringe under real-time 
US guidance (Figs. 2 and 3). A straight guid-
ing catheter was used to remove thrombus 
in regular straight veins whereas a guiding 
catheter with angled tip was preferred in a 
convoluted vein. 
The distance from the puncture site to 
the estimated proximal common iliac vein 
was measured and the guiding catheter 
was intended to aspirate thrombus up to 
the level of common iliac vein. The guiding 
catheter was gently advanced without a 
guidewire. During the advancement of the 
guiding catheter, negative pressure was ap-
plied to aspirate the thrombus. If there was 
a resistance to the advancement of guiding 
catheter in a convoluted vein, the catheter 
was advanced over a hydrophilic guidewire 
or an angled guiding catheter was rotated 
for safe advancement to prevent dissec-
tion. Aspiration was performed from the 
caudal to cranial ends of thrombosed veins. 
The most cranial part was aspirated last to 
prevent or decrease the risk of PE. The pro-
cedure was repeated several times until 
complete or significant thrombus removal 
was achieved and uninterrupted venous 
flow was observed on CDUS. The veins in 
the thigh could be visualized on CDUS, but 
it was not possible to visualize the iliac veins 
from a posterior approach when the patient 
was lying prone.
The patients were admitted for one day 
of anticoagulation after the procedure and 
discharged the next day. Subcutaneous 
heparin and graduated elastic compression 
stockings were recommended to all pa-
tients until the end of the postpartum pe-
riod. Patients were called for follow-up vis-
its at three months after delivery. Patency 
was assessed by physical examination and 
CDUS. Venography was obtained if there 
was any clinical doubt regarding the paten-
cy of the iliac veins. 
Main points
• Ultrasonography (US)-guided percutaneous 
aspiration thrombectomy can be used as a 
rapid and effective method for removal of 
thrombus in pregnant women with massive 
leg swelling similar to phlegmasia alba 
dolens. 
• Percutaneous aspiration thrombectomy can 
be performed safely under US guidance.
• Use of percutaneous aspiration thrombectomy 
may require experience. Therefore it may not 
be easily recommended to those who have less 
experience in using this method.
• The use of percutaneous aspiration thrombec-
tomy under US guidance in pregnant women 
is justifiable because of the absence of other 
viable treatment options.
Figure 1. a–c. Preprocedure preparation. Panel (a) shows puncture of the popliteal vein under US guidance; (b) shows insertion of a vascular sheath; panel 
(c) shows straight and angled large bore guiding catheters.
a b c
Statistical analysis 
Statistical analyses were performed us-
ing SPSS v. 17 (SPSS Inc.). Numeric data are 
expressed as mean±standard deviation or 
percentage.
Results 
Six patients with only femoropopliteal 
DVT or mild symptoms of DVT were exclud-
ed from the study. All nine patients were 
severe symptomatic cases with massive 
swelling and pain of the leg. Five patients 
were in the first trimester of pregnancy, 
two were in the second trimester, and two 
in the last trimester. None of the patients 
had a previous history of DVT or major PE 
symptoms. The lesion was on the left side in 
seven patients (77.8%) and on the right side 
in two patients (22.2%). All patients had 
anticoagulation therapy with heparin until 
diagnostic evaluation or potential conse-
quent endovascular therapy. DVT was acute 
(1–14 days) in four patients (44.4%), acute 
and subacute (15–28 days) in five patients 
(55.6%). Seven patients had involvement 
of the iliac, femoral, popliteal, and crural 
veins. The popliteal and crural veins were 
patent in two patients with thrombosis of 
femoral and iliac veins. Thrombus was also 
present in the proximal GSV in three pa-
tients and in the proximal SSV in a patient 
because of descending DVT, probably due 
to May-Thurner syndrome. Initial access to 
the venous system was through the pop-
liteal vein in all patients. Two patients had 
additional GSV access and one patient had 
an additional SSV access to remove throm-
bus and improve blood flow to the femoral 
and iliac veins. 
Complete or significant thrombus re-
moval and uninterrupted venous flow from 
the puncture site up to the iliac veins were 
achieved in all patients at first intervention. 
Complete relief of leg pain was achieved 
immediately in seven patients (77.8%), but 
minimal swelling remained around the an-
kle. Two patients (22.2%) had a recurrence 
of thrombosis in the first week postinter-
vention. One of the two underwent a sec-
ond intervention and PAT was performed 
again with successful removal of thrombus 
and establishment of in line flow. The other 
patient refused a second intervention. None 
of the patients required blood transfusion 
because of blood loss during thrombus ex-
traction. The average volume of blood aspi-
rated as thrombus ranged 200–400 mL for 
each patient. 
Two patients were lost to follow-up after 
birth. Two patients were followed with only 
CDUS and five patients underwent venog-
raphy after birth. None of these patients 
had rethrombosis throughout the postpar-
tum period. Symptomatic relief was detect-
ed clinically in these seven patients. Venous 
patency was demonstrated with CDUS and 
venography (Fig. 4). Venography also re-
vealed left common iliac vein compression 
syndrome (May-Thurner syndrome) in three 
patients (33.3%). 
Discussion 
This study showed that PAT can be per-
formed safely under US guidance as a 
thrombus removal method in pregnant 
women with acute or subacute iliofemoral 
DVT. We achieved complete or near com-
plete thrombus removal and rapid symp-
tomatic relief in seven of nine patients 
US-guided percutaneous aspiration thrombectomy of DVT in pregnancy • 73
Figure 2. a–c. Aspiration thrombectomy procedure under real-time US guidance. 
a
b c
Figure 3. a–c. Appearance of thrombus at different stages.  
a b c
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without any complications related to the 
procedure. 
The risk of VTE increases 4- to 5-fold 
during pregnancy and 20-fold or more in 
the postpartum period. The main reason for 
increased risk of VTE is the hypercoagulable 
state of pregnancy which protects women 
from bleeding during miscarriage or child-
birth. Other underlying factors include ve-
nous stasis and vascular damage. DVT and 
PE are two different manifestations of VTE. 
PE is the leading cause of maternal deaths 
(1, 2, 9). Anticoagulation with heparin reduc-
es the risk of PE and is currently considered 
the standard of care for the prevention of PE. 
However, the management of DVT remains 
a major clinical problem because this form 
of therapy does not adequately protect the 
patient from the development of PTS. Res-
olution of the present thrombus formed in 
the deep veins is slow and frequently in-
adequate in this form of therapy (3, 4). In a 
previous study, 4% of patients treated with 
heparin had significant or complete lysis, 
whereas 14% of patients had partial lysis (3). 
Lysis did not occur in 82% of patients who 
either failed to improve or worsened. Per-
sistence of thrombus in the deep veins leads 
to venous outflow obstruction and valvular 
incompetence, which is ultimately the cause 
of PTS in most patients (4–8). Data from the 
National Venous Thrombolysis Registry, 
strongly point to a relationship between the 
degree of lysis and venous valvular function; 
62% of patients with <50% lysis had valvu-
lar incompetence, whereas 72% of patients 
who had complete lysis had normal valve 
function (15). Patients who progress to PTS 
could have a poor quality of life and disabili-
ty due to clinical features of post-thrombotic 
sequelae including lifestyle-limiting chronic 
leg pain and edema, heaviness, and/or fa-
tigue, and in severely affected patients ve-
nous claudication, varicosities, stasis derma-
titis, hyperpigmentation and subsequently 
venous stasis ulcers (4–8). 
A preponderance of the evidence in pa-
tients with lower extremity DVT suggests 
a strategy of early thrombus elimination 
for fast symptom relief and restoration of 
venous patency to protect valve function 
and prevent development of the PTS (4–8, 
15–24). Alternative treatment options have 
been used to remove thrombus from deep 
veins because of the disappointing results 
with anticoagulation therapy (16–18). Pub-
lished evidence indicates that thrombolytic 
agents, even when administered systemical-
ly, are superior to anticoagulation therapy for 
achieving early lysis of thrombus. Comerota 
and Aldridge (3) stated that 45% of patients 
treated with systemic thrombolysis had sig-
nificant or complete lysis compared with 
4% of patients treated with heparin. Among 
those receiving systemic thrombolysis, 18% 
had partial lysis, while 37% failed to improve 
or worsened. Despite its potential benefits, 
thrombolysis is associated with a greater 
risk of minor or major bleeding complica-
tion than anticoagulation therapy. Cathe-
ter-directed thrombolysis (CDT) was recom-
mended in selected patients with extensive 
acute proximal DVT (e.g., iliofemoral DVT, 
symptoms lasting <14 days, good functional 
status, life expectancy of >1 year) who have 
a low risk of bleeding (25). It may be used to 
reduce acute symptoms and post-throm-
botic morbidity if appropriate expertise 
and resources are available. CDT offers dis-
tinct advantages compared with systemic 
thrombolysis, and anticoagulation alone. 
Catheter-directed infusion allows higher 
concentrations of the thrombolytic agent 
to be delivered directly into the thrombus 
with a reduced systemic effect (15–19, 24). 
A recent comparative study (18) provides 
support for the potential of adjunctive CDT 
to prevent PTS. In this study, patients with 
iliofemoral DVT treated with CDT had a sig-
nificantly decreased the frequency of PTS 
and better health-related quality of life com-
pared with patients treated with anticoagu-
lation alone. A study of systemic thromboly-
sis use versus CDT in treating iliofemoral DVT 
demonstrated that CDT may be superior to 
systemic thrombolysis in preserving venous 
valvular function (19). They also found that 
in CDT group, the needed dose of thrombo-
lytic agents was lower and the duration of 
treatment was shorter. On the other hand, 
CDT has some potential disadvantages that 
include the long infusion times required to 
lyse extensive DVT, lengthy hospital stays, 
greater bleeding risk and high medication 
and hospitalization costs (15,16). Recent-
ly, percutaneous thrombectomy methods 
alone or combined with CDT have been 
widely used as an effective endovascular 
method for thrombus removal. Compared 
with CDT, percutaneous thrombectomy 
methods are able to remove the thrombus 
more rapidly without the risk of bleeding 
complication (17, 20–24, 26–29). Vedantham 
et al. (20) found that the use of adjunctive 
percutaneous mechanical thrombectomy to 
augment CDT provides comparable proce-
dural success and may reduce thrombolytic 
dose requirements and infusion times. PAT 
has been successfully used alone or in com-
bination with local thrombolytic infusion to 
remove thromboembolic material from limb 
arteries (27, 28). PAT is a cheap and simple 
method. It proposes a rapid and effective 
way to remove thrombus. Moreover, it can 
be used in almost every patient who is unre-
sponsive to anticoagulation therapy or has a 
contraindication to thrombolysis (22, 27–29). 
Figure 4. a, b. Venography performed in the postpartum period. Panel (a) shows irregular but patent 
femoral veins. The iliac veins completely thrombosed before the procedure seem patent with iliac 
vein compression (b).
a b
PAT has also been effectively used alone or 
in combination with thrombolysis to treat 
lower extremity DVT (22, 29). The efficacy 
of PAT as the primary method of thrombus 
removal has been previously shown in 139 
patients with acute and subacute iliofemoral 
DVT (22). In that study, successful recanaliza-
tion without the use of CDT was achieved in 
the majority of patients. CDT was required 
in only one-fourth of the patients as an ad-
junctive treatment following PAT. In other 
patients who required CDT, the dose of the 
thrombolytic agent was quite low.
The management of DVT in pregnancy is 
still challenging for several reasons. DVT is 
generally treated with intravenous or sub-
cutaneous heparin during pregnancy and 
the postpartum period, but the subsequent 
risk of post-thrombotic complication devel-
opment in this young patient population is 
a concern. Many interventional radiologic 
treatment modalities that are extensive-
ly used in nonpregnant patients, have not 
been appropriately validated in pregnancy. 
Image-guided interventional thrombus re-
moval procedures are potentially hazard-
ous to the fetus in terms of adverse effects 
of ionizing radiation and contrast agent. 
Pregnancy and the peripartum period are 
generally considered as a contraindication 
for thrombolytic therapy because of the 
risk of uncontrolled bleeding complication 
(9). However, a few case reports have been 
published describing thrombolytic therapy 
of DVT during pregnancy and in the peri- or 
postpartum period (10–13, 30). Henrich et al. 
(10) performed systemic streptokinase lysis 
without complications in a pregnant wom-
an at 29 weeks of gestation who had acute 
iliac DVT. They concluded that thrombolytic 
therapy during pregnancy is possible and 
may help to prevent serious long-term se-
quelae of DVT in these young patients. They 
also stated that the risk of bleeding must 
be considered and thrombolytic therapy 
should only be administered under close 
observation. In a study by Krishnamurthy 
et al. (11), a pregnant woman with PE, se-
riously ill, and two pregnant women with 
iliofemoral DVT who failed to respond to 
treatment with intravenous heparin were 
treated with catheter-directed urokinase. 
All three patients had fast symptom relief 
and successful pregnancy outcomes. They 
suggested that CDT offered a reasonably 
safe alternative therapy in these young 
women and may prevent PTS in the long-
term. Patterson et al. (12) treated a patient 
with iliac vein thrombosis 48 hours after 
delivery with catheter-directed urokinase 
because there was no clinical improvement 
despite heparin infusion. Acharya et al. (13) 
used CDT to treat four women with acute 
postpartum iliofemoral DVT (within 42 days 
of childbirth) and achieved a successful re-
sult and symptom relief in all four patients. 
Demirturk et al. (30) reported that endovas-
cular treatment of postpartum iliofemoral 
DVT (within 42 days of childbirth) with PAT 
alone or combined with CDT was rapid, 
very safe and resulted in a very high rate of 
thrombus removal in 18 patients. In a pre-
vious study (14), a pregnant woman with 
DVT underwent percutaneous mechanical 
thrombectomy with the use of venograms 
because pregnancy was considered a con-
traindication to thrombolysis. Thrombus 
removal using PAT with or without fluoros-
copy guidance has not been used to date 
in pregnant women with iliofemoral DVT. 
Our institution prefers a strategy of early 
thrombus elimination as quickly as possi-
ble, particularly in young patients, to relieve 
symptoms and minimize the development 
of long-term sequelae. For this purpose, we 
performed PAT under US guidance to treat 
our pregnant patients with iliofemoral DVT. 
Full systemic anticoagulation remains an 
essential element of our treatment to pre-
vent PE and recurrent thrombosis. 
Our study is limited by its retrospective 
nature. Technical success and short-term 
patency were good, but the mid- and long-
term results are not known in our patients. 
Thus, our results must be considered pre-
liminary. Use of PAT may require experience. 
Our center has been using this method for 
the last 15 years and is quite experienced in 
using PAT for thrombus removal. Therefore 
it may not be easily recommended to those 
who have less experience in using this meth-
od. Nonetheless, the use of PAT in pregnant 
women is justifiable because of the absence 
of other viable treatment options. 
In conclusion, endovascular treatment 
with US-guided PAT can be considered as a 
safe and effective way to remove thrombus 
from the deep veins in pregnant women 
with acute and subacute iliofemoral deep 
vein thrombosis. 
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